Show your commitment and help fund Patient Group accommodation at the event
Patient input is critical to an orphan drug’s success
- from understanding the patient journey through better clinical trial design to post-launch support initiatives, patients are essential and knowledgeable partners for Pharma.
For years now the
World Orphan Drugs Congress Europe
has been a strong advocate of inviting and funding as many patient groups as possible, by partnering with EURORDIS and NORD and investing in fully subsidising their conference tickets, food and drink each year to help them attend the event.
To increase their participation further we are offering the chance for a number of interested
“Patient Group Supporters”
at the 2018 event, to show your commitment to involving patient groups throughout the drug development lifecycle.
Contributing as a Patient Group Supporter your investment will go directly towards helping the patient groups costs incurred for accommodation at the event (all funds go back into supporting patients), where we will also have a dedicated
on one of the days where you will get to meet those who you have helped be there. A great opportunity to be seen as actively championing and working with the industries Patient Groups.
Patient Group Sponsor
Contribute directly to helping Patient Groups be part of the World Orphan Drugs Congress Europe 2018
Participation and branding at dedicated luncheon specifically for Pharma supporters and Patient Groups – a great opportunity for Pharma to be seen as championing and working with the industries Patient Groups
Company Logo on event brochure, event banners, signage and delegate workbook handed out to all attendees
Company Logo and profile on event website with a link to your profile and website